Entrada Therapeutics (TRDA) Short-term Investments (2022)
Historic Short-term Investments for Entrada Therapeutics (TRDA) over the last 1 years, with Q3 2022 value amounting to $162.3 million.
Historic Short-term Investments for Entrada Therapeutics (TRDA) over the last 1 years, with Q3 2022 value amounting to $162.3 million.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month